RBTT-01. RANDOMIZED PHASE 2 OPEN LABEL STUDY OF NIVOLUMAB PLUS STANDARD DOSE BEVACIZUMAB VERSUS NIVOLUMAB PLUS LOW DOSE BEVACIZUMAB IN RECURRENT GLIOBLASTOMA

Manmeet Ahluwalia; David Peereboom; Cathy Schilero; Deborah Forst; Eric Wong; Patrick Wen; David Reardon

doi:10.1093/neuonc/noy148.971

RBTT-01. RANDOMIZED PHASE 2 OPEN LABEL STUDY OF NIVOLUMAB PLUS STANDARD DOSE BEVACIZUMAB VERSUS NIVOLUMAB PLUS LOW DOSE BEVACIZUMAB IN RECURRENT GLIOBLASTOMA

Neuro-Oncology ◽

10.1093/neuonc/noy148.971 ◽

2018 ◽

Vol 20 (suppl_6) ◽

pp. vi234-vi234 ◽

Cited By ~ 2

Author(s):

Manmeet Ahluwalia ◽

David Peereboom ◽

Cathy Schilero ◽

Deborah Forst ◽

Eric Wong ◽

...

Keyword(s):

Low Dose ◽

Standard Dose ◽

Recurrent Glioblastoma ◽

Phase 2 ◽

Open Label ◽

Open Label Study ◽

Label Study ◽

Randomized Phase 2

Download Full-text

O-11 Trastuzumab deruxtecan (T-DXd; DS-8201) in patients with HER2-positive advanced gastric or gastroesophageal junction adenocarcinoma: A randomized, phase 2, multicenter, open-label study (DESTINY-Gastric01)

Annals of Oncology ◽

10.1016/j.annonc.2020.04.064 ◽

2020 ◽

Vol 31 ◽

pp. 235

Author(s):

K. Yamaguchi ◽

Y. Bang ◽

S. Iwasa ◽

N. Sugimoto ◽

M. Ryu ◽

...

Keyword(s):

Gastroesophageal Junction ◽

Phase 2 ◽

Her2 Positive ◽

Open Label ◽

Open Label Study ◽

Label Study ◽

Gastroesophageal Junction Adenocarcinoma ◽

O 11 ◽

Randomized Phase 2

Download Full-text

Immune response from STRIDE, a randomized, phase 2, open label study of sipuleucel-T (sip-T) with concurrent vs sequential enzalutamide (enz) administration in metastatic castration-resistant prostate cancer (mCRPC).

Journal of Clinical Oncology ◽

10.1200/jco.2015.33.15_suppl.5040 ◽

2015 ◽

Vol 33 (15_suppl) ◽

pp. 5040-5040 ◽

Cited By ~ 2

Author(s):

David I. Quinn ◽

Charles G. Drake ◽

Robert Dreicer ◽

Emmanuel S. Antonarakis ◽

Neal D. Shore ◽

...

Keyword(s):

Prostate Cancer ◽

Immune Response ◽

Phase 2 ◽

Castration Resistant Prostate Cancer ◽

Open Label ◽

Open Label Study ◽

Label Study ◽

Castration Resistant ◽

Randomized Phase 2

Download Full-text

A randomized phase 2, multicenter, open-label study of trastuzumab deruxtecan (DS-8201a) in subjects with HER2-expressing gastric cancer.

Journal of Clinical Oncology ◽

10.1200/jco.2018.36.15_suppl.tps4133 ◽

2018 ◽

Vol 36 (15_suppl) ◽

pp. TPS4133-TPS4133 ◽

Cited By ~ 2

Author(s):

Kensei Yamaguchi ◽

Yung-Jue Bang ◽

Daisuke Sakai ◽

Hisateru Yasui ◽

Yoshinori Kawaguchi ◽

...

Keyword(s):

Gastric Cancer ◽

Phase 2 ◽

Open Label ◽

Open Label Study ◽

Label Study ◽

Randomized Phase 2

Download Full-text

2526 Immune responses and clinical data from STRIDE, a randomized, phase 2, open label study of sipuleucel-T with concurrent vs sequential enzalutamide administration in metastatic castrationresistant prostate cancer

European Journal of Cancer ◽

10.1016/s0959-8049(16)31345-4 ◽

2015 ◽

Vol 51 ◽

pp. S483 ◽

Cited By ~ 3

Author(s):

D. Petrylak ◽

D. Quinn ◽

R. Dreicer ◽

E. Antonarakis ◽

N. Shore ◽

...

Keyword(s):

Prostate Cancer ◽

Immune Responses ◽

Clinical Data ◽

Phase 2 ◽

Open Label ◽

Open Label Study ◽

Label Study ◽

Randomized Phase 2

Download Full-text

Multifocal ERG and Microperimetry Changes in Response to Ranibizumab Treatment of Neovascular AMD: Randomized Phase 2 Open-Label Study

Clinical Ophthalmology ◽

10.2147/opth.s270243 ◽

2020 ◽

Vol Volume 14 ◽

pp. 3599-3610

Author(s):

Masumi G Asahi ◽

Josh Wallsh ◽

Spencer M Onishi ◽

Shari Kuroyama ◽

Ron P Gallemore

Keyword(s):

Multifocal Erg ◽

Phase 2 ◽

Neovascular Amd ◽

Open Label ◽

Open Label Study ◽

Label Study ◽

Randomized Phase 2 ◽

Ranibizumab Treatment

Download Full-text

Stride, a Randomized, Phase 2, Open-Label Study of Sipuleucel-T with Concurrent Vs Sequential Enzalutamide in Metastatic Castration-Resistant Prostate Cancer (Mcrpc)

Annals of Oncology ◽

10.1093/annonc/mdu336.22 ◽

2014 ◽

Vol 25 ◽

pp. iv266

Author(s):

D.P. Petrylak ◽

D.I. Quinn ◽

R. Dreicer ◽

E.S. Antonarakis ◽

N.D. Shore ◽

...

Keyword(s):

Prostate Cancer ◽

Phase 2 ◽

Castration Resistant Prostate Cancer ◽

Open Label ◽

Open Label Study ◽

Label Study ◽

Castration Resistant ◽

Randomized Phase 2

Download Full-text

O-14 Exploratory biomarker analysis of trastuzumab deruxtecan in DESTINY-Gastric01, a randomized, phase 2, multicenter, open-label study in patients with HER2-positive or -low advanced gastric or gastroesophageal junction adenocarcinoma

Annals of Oncology ◽

10.1016/j.annonc.2021.05.018 ◽

2021 ◽

Vol 32 ◽

pp. S224

Author(s):

K. Shitara ◽

Y. Bang ◽

S. Iwasa ◽

N. Sugimoto ◽

M. Ryu ◽

...

Keyword(s):

Gastroesophageal Junction ◽

Phase 2 ◽

Her2 Positive ◽

Open Label ◽

Open Label Study ◽

Label Study ◽

Gastroesophageal Junction Adenocarcinoma ◽

Biomarker Analysis ◽

Randomized Phase 2

Download Full-text

Pharmacokinetic Drug–Drug Interactions Between Vonoprazan and Low-Dose Aspirin or Nonsteroidal Anti-inflammatory Drugs: A Phase 2, Open-Label, Study in Healthy Japanese Men

Clinical Drug Investigation ◽

10.1007/s40261-016-0455-2 ◽

2016 ◽

Vol 37 (1) ◽

pp. 39-49 ◽

Cited By ~ 4

Author(s):

Yuuichi Sakurai ◽

Madoka Shiino ◽

Sayako Horii ◽

Hiroyuki Okamoto ◽

Koki Nakamura ◽

...

Keyword(s):

Low Dose ◽

Phase 2 ◽

Open Label ◽

Japanese Men ◽

Open Label Study ◽

Label Study ◽

Dose Aspirin ◽

Low Dose Aspirin ◽

Inflammatory Drugs ◽

Pharmacokinetic Drug

Download Full-text

Faculty Opinions recommendation of Neridronate improves bone mineral density and reduces back pain in β-thalassaemia patients with osteoporosis: results from a phase 2, randomized, parallel-arm, open-label study.

Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature ◽

10.3410/f.717797810.793153212 ◽

2012 ◽

Author(s):

Klaus Klaushofer

Keyword(s):

Bone Mineral Density ◽

Back Pain ◽

Bone Mineral ◽

Phase 2 ◽

Mineral Density ◽

Open Label ◽

Open Label Study ◽

Label Study

Download Full-text

Results of a phase 2, multicenter, single‐arm, open‐label study of lenalidomide in pediatric patients with relapsed or refractory acute myeloid leukemia

Pediatric Blood & Cancer ◽

10.1002/pbc.28946 ◽

2021 ◽

Author(s):

Maureen M. O'Brien ◽

Todd A. Alonzo ◽

Todd M. Cooper ◽

John E. Levine ◽

Patrick A. Brown ◽

...

Keyword(s):

Acute Myeloid Leukemia ◽

Myeloid Leukemia ◽

Pediatric Patients ◽

Phase 2 ◽

Open Label ◽

Open Label Study ◽

Label Study ◽

Refractory Acute Myeloid Leukemia ◽

Acute Myeloid

Download Full-text